Cardinal Health, Inc. (CAH), a Healthcare Medical Distribution business, saw its stock exchange 59.29 common shares, a spike against to its 10-day trading volume of 3.37M.
Cardinal Health, Inc. (CAH) stock traded at $59.29, up 6.61 cents or +12.55% on the day. Based on this we can see some traders are either waiting on the sidelines to get involved or perhaps some are taking profits.
Total Revenue for Cardinal Health, Inc. (CAH) is $147.66B, Gross Profit is $6.83B and the EBITDA is $2.86B.
Cardinal Health, Inc. (CAH) Technical Evaluation:
The average 10-day trading volume of Cardinal Health, Inc. (CAH) is 3.37M compared to 2.57M over the last 3 months which indicates a spike in trading activity. Currently, Cardinal Health, Inc. (CAH) has a 50-day moving average of $51.94 and a 200-day moving average of $49.44. These moving averages are popular technical statistics that investors use to analyze price trends of Cardinal Health, Inc. (CAH).
Approximately 4.14% of the shares of the company are sold short from investors betting the shares might trade lower. The beta value on Cardinal Health, Inc. (CAH) stock is 1.38, indicating its 2.82% to 2.33% more volatile than the overall market.
Technically, CAH’s short term support levels are around $52.20, $50.70 and $49.22 on the downside. CAHs short term resistance levels are $56.30, $55.32 and $54.21 on the upside.
Based on technical analysis, CAH has short term rating of Neutral (-0.02), Intermediate rating of Very Bullish (0.60) and the long-term rating of Neutral (0.14) giving it an overall rating of Neutral (0.24).
CAH is trading 44.31% off its 52 week low at $41.03 and 4.10% off its 52 week high of $56.88. Performance wise, CAH stock has recently shown investors -1.97% a slope in a week, 5.85% a spike in a month and 1.82% a spike in the past quarter.
More importantly, Cardinal Health, Inc. (CAH) has shown a return of 4.15% since the 1st of this year.
Cardinal Health, Inc. (CAH) Key Figures:
Cardinal Health, Inc. (CAH) is a large-cap company with a market cap value of $17.342B. CAH insiders hold roughly 0.16% of the shares.
On Aug-27-19 Argus Downgrade CAH as Buy → Hold, On Sep-12-19 Deutsche Bank Initiated CAH as Hold and on Dec-16-19 Guggenheim Downgrade CAH as Buy → Neutral.
There are currently 292.03M shares in the float and 304.37M shares outstanding. There are 4.14% shares short in CAHs float.
The industry rank for Cardinal Health, Inc. (CAH) is 107 out of 255 ranking it at the Top 42% .
Cardinal Health, Inc. (CAH) Fundamental Data:
CAH last 2 years revenues have increased from $145,534,000 to $147,662,000 showing an uptrend.
Wall Street expects Cardinal Health, Inc. (CAH) to report an EPS next Qtr profit of 1.22 and a profit of 4.84% next year.
The growth rate on CAH this year is -4.17 compared to an industry 10.70. However, CAHs next year’s growth rate is 4.74 compared to an industry 14.90.
The book value per share (mrq) is 3.04 and cash per share (mrq) is 3.98. Giving them a price/book (mrq) of 17.06 compared to an industry of 3.69 and CAHs price/cash flow (mrfy) is 6.06 compared to an industry of 12.42.
CAH fundamental ratios shows an EPS growth vs. previous year 5.06 and EPS growth vs. previous quarter 1.21.
About Cardinal Health, Inc. (CAH):
Headquartered in Dublin, OH, Cardinal Health Inc. is a nation-wide drug distributor and provider of services to pharmacies, healthcare providers and manufacturers. The company has two reporting segments – Pharmaceutical and Medical.The Pharmaceutical segment is the second largest pharmaceutical distributor in the United States and the largest nuclear pharmacy. Its products and services include pharmaceutical distribution, manufacturer and specialty services, and nuclear and pharmacy services. This segment also offers “specialty pharmaceutical products and services”, which supplies (1) oncology, rheumatology, urology and other pharmaceutical products to physician offices; (2) human plasma products and specialty pharmaceutical products to hospitals and other healthcare providers; (3) consulting and other services to pharmaceutical manufacturers, third party payors and healthcare providers.The Medical segment manufactures products such as single-use surgical drapes, gowns and apparel; exam and surgical gloves; and fluid suction and collection systems and offers sterile and non-sterile procedure kits. These products are sold directly or distributed via third-party sources in the U.S., Canada, Europe, South America and the Asia/Pacific. FY19 at a GlanceIn fiscal 2019, Cardinal Health registered adjusted earnings of $5.28 per share, up 5.6% on a year-over-year basis. Revenues increased 6.4% on a year-over-year basis to a record $145.53 billion. Delving deeper into the segmental revenue details, Pharmaceutical (89.3% of net revenues) increased 7.2% to $129.92 billion in fiscal 2019. Medical revenues (10.7% of net revenues) rose 0.3% on a year-over-year basis to $15.63 billion.Important Acquisitions & DivestmentsOn Feb 1, 2018, Cardinal Health announced the divestiture of its Cardinal Health China business to Shanghai Pharmaceuticals Holding Co., Ltd. for $1.2 billion.